MSCM
INSM icon

McElhenny Sheffield Capital Management’s Insmed INSM Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24
Closed -$480 – 336
2022
Q4 		$480 Buy
+24
New +$464 ﹤0.01% 633

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

McElhenny Sheffield Capital Management's INSM Position: Q1 2023 in Review

McElhenny Sheffield Capital Management sold out of Insmed (INSM) in Q1 2023, closing a stake of 24 shares — an estimated $480 sold.

McElhenny Sheffield Capital Management first reported a position in INSM in Q4 2022 and held it in 1 quarter. The position peaked at $480 in Q4 2022. 230 funds tracked by Wall St. Rank hold INSM as of Q1 2023.

  • McElhenny Sheffield Capital Management reported no remaining Insmed position as of Q1 2023 after selling out during the quarter.
  • McElhenny Sheffield Capital Management sold 24 Insmed shares in Q1 2023, an estimated $480.
  • McElhenny Sheffield Capital Management first reported a position in Insmed in Q4 2022 and held it in 1 quarter.
  • McElhenny Sheffield Capital Management's Insmed position peaked at $480 in Q4 2022.
  • 230 funds tracked by Wall St. Rank held Insmed as of Q1 2023.

Based on McElhenny Sheffield Capital Management's 13F filing for Q1 2023, filed 13 Apr 2023.